Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Medplus Health Services Ltd Performance

Today's Low
680.20
arrowIcon
Today's High
700.05
52 Wk Low
598.60
arrowIcon
52 Wk High
978.00


Open

680.2

Traded Value (Cr)

4.87 Cr

Prev. Close

696.25

VWAP

692.04

Volume

1,92,843

Face Value

2

Medplus Health Services Ltd Fundamentals

Market Cap
₹ 8,062 Cr
P/E Ratio (TTM)
137.36
P/B Ratio
5.29
Debt to Equity
0.63
ROE
3.83 %
EPS (TTM)
4.91
Dividend Yield
0.00%
Book Value
127.39

Click here to know more about Fundamentals

Medplus Health Services Ltd Financials

Medplus Health Services Ltd Financials

Medplus Health Services Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 40.39 % 40.45 % 40.41 % 40.43 %
Others 24.50 % 25.04 % 25.23 % 36.46 %
FII 14.94 % 12.97 % 12.36 % 4.86 %
Mutual Funds 12.87 % 15.40 % 15.60 % 12.41 %
Retail 7.30 % 6.15 % 6.40 % 5.83 %

Promoters

40.39%

Others

24.50%

FII

14.94%

Mutual Funds

12.87%

Retail

7.30%

Promoters

40.45%

Others

25.04%

FII

12.97%

Mutual Funds

15.40%

Retail

6.15%

Promoters

40.41%

Others

25.23%

FII

12.36%

Mutual Funds

15.60%

Retail

6.40%

Promoters

40.43%

Others

36.46%

FII

4.86%

Mutual Funds

12.41%

Retail

5.83%

Resistance and Support

₹686.55

PIVOT

resistance-arrow
Resistance
First Resistance₹693.650
Second Resistance₹700.100
Third Resistance₹707.200
support-arrow
Support
First Resistance₹680.100
Second Resistance₹673.000
Third Resistance₹666.550
RSI55.862
MACD4.213
ADX12.358
CCI56.359

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day192,84338,54555.01
Week139,07382,13972.37
1 Month115,41979,43563.89
6 Months192,84399,18451.43

About Medplus Health Services Ltd

MedPlus Health Services Limited was incorporated as a Private Limited Company with the name 'MedPlus Health Services Private Limited' at Hyderabad on 30 November, 2006. The Company converted from a Private Limited Company to a Public Limited Company, pursuant to a Special Resolution passed by Shareholders at the Extra Ordinary General Meeting held on 01 June 2021 and name of the Company was changed to MedPlus Health Services Limited on 28 June 2021. The Company is engaged in providing pathological laboratory testing and manufacturing, trading and contract manufacturing of pharma, FMCG and beauty products and rendering of management services to group companies and holds investments in subsidiary companies. The Company has six direct subsidiaries and five step-down subsidiaries. MedPlus is the second largest pharmacy retailer in India in terms of revenue and number of stores as of 31 March 2021.The company offer a wide range of products, including (i) pharmaceutical and wellness products, including medicines, vitamins, medical devices and test kits, and (ii) fast-moving consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers.The company grown from operating initial 48 stores in Hyderabad at the conception of the business to operating India's second largest pharmacy retail network of over 2,000 stores distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal and Maharashtra, as of 31 March 2021.The number of stores has grown since the conception of the business and, as of 30 June 2021, MedPlus operated 520 stores in Karnataka, 458 stores in Tamil Nadu, 443 stores in Telangana, 274 stores in Andhra Pradesh, 201 stores in West Bengal, 186 stores in Maharashtra and 83 stores in Odisha. On 21 January 2021, the Company has issued and allotted 254674 equity shares of Rs 10 each as bonus shares to the shareholders in the ratio of 1.25:1. On 05 August 2021,the company has allotted 29910085 equity shares of Rs 2 each on conversion of preference shares.The allotment of 14,976,000 Equity Shares to Gangadi Madhukar Reddy upon conversion of 2,995,200 Series B CCPS held by it,6,660,575 Equity Shares to Agilemed Investments Private Limited upon conversion of 1,332,115 Series B1 CCPS held by it and 8,273,510 Equity Shares to Lone Furrow Investments Private Limited upon conversion of 1,654,702 Series B2 CCPS. During the month of December 2021,the company cameout with an Rs 1398.30-crore public issue which comprised a fresh issue of Rs 600 crore and an offer for sale(OFS) of Rs 798.30 crore by selling shareholders.The IPO shares were allotted at the price of Rs 796 per share including a premium of Rs 794 per share.The net proceeds of the fresh issue will be utilised for funding working capital requirement of subsidiary,Optival and general corporate purposes.The allotted shares were listed on the BSE Ltd and National Stock Exchange of India Ltd(NSE) on 23 December 2021. During the year 2021-22, 747 stores were increased to the cluster store network of the Group. In March 2022, the Company launched its first Diagnostic Centre in Gachibowli, Hyderabad. It marked the presence with 2,748 Physical Stores during the year 2022. During the year 2022-23, 1144 stores were added to the cluster store network of the Company. As on March 31, 2023 the Company's total fleet of stores stood at 3822. The Company launched its Diagnostic Services Centre in the year 2021 as pilot project. During the year 2022-23, the Company incorporated a Subsidiary Company namely MedPlus Insurance Brokers Private Limited.

Managing Director

GANGADI MADHUKAR REDDY

Founded

2006

NSE Symbol

MEDPLUS

Medplus Health Services Ltd Management

NameDesignation
GANGADI MADHUKAR REDDYChairman & MD & CEO
Anish SarafDirector
Atul GuptaNominee
Murali SivaramanIndependent Director
Madhavan GanesanIndependent Director
Hiroo MirchandaniIndependent Director
Manoj Kumar SrivastavaCompany Sec. & Compli. Officer

Medplus Health Services Ltd News

Medplus Health Services schedules board meeting
On 28 May 2024
Medplus Health Services standalone net profit rises 414.52% in the December 2023 quarter
Sales rise 158.74% to Rs 148.10 crore
Medplus Health Services consolidated net profit rises 2.39% in the December 2023 quarter
Sales rise 21.10% to Rs 1441.47 crore
Medplus Health Services to declare Quarterly Result
On 2 February 2024
Medplus Health Services announces resignation
Medplus slides after arm’s suspension of drug license
Medplus slipped 3.09% to Rs 723.50 after the firm informed that Drugs and Control Authority, Government of Telangana, suspended license of a subsidiary company for five days effective from 20 December 2023.
Medplus Health Services to hold EGM
On 15 December 2023
Medplus Health Services consolidated net profit rises 121.61% in the September 2023 quarter
Sales rise 25.70% to Rs 1408.59 crore
Medplus Health Services to discuss results
On 26 October 2023
Medplus Health Board to mull fund raising on 11 Oct
Medplus health Services said that its board will meet on 11 October 2023, to consider raising of funds via equity shares or non-convertible debentures (NCDs).

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
DMART₹ 3,05,584 Cr
₹ 4,696.00
(1.49 %)
117.87
TRENT₹ 1,47,845 Cr
₹ 4,158.95
(1.76 %)
166.50
ABFRL₹ 23,527 Cr
₹ 231.55
(0.78 %)
0.00
MANYAVAR₹ 22,302 Cr
₹ 918.30
(1.72 %)
55.02
REDTAPE₹ 9,738 Cr
₹ 704.65
(-0.24 %)
59.12

Medplus Health Services Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Medplus Health Services Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Medplus Health Services Ltd's share price is ₹694.40 as of April 19, 2024

Medplus Health Services Ltd's P/E ratio is 137.36 times as of April 19, 2024.

Medplus Health Services Ltd's most recent financial reports indicate a price-to-book ratio of 5.29, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Medplus Health Services Ltd's market is 8,062 Cr as on April 19, 2024.

The current financial records of Medplus Health Services Ltd show a 3.83% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Medplus Health Services Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Medplus Health Services Ltd's 52-week high and low as of April 19, 2024 are ₹700.05 and ₹680.2 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Medplus Health Services Ltd stands at 40.39%. During the same period, Institutional Investors have shown a slight increase in their holdings, rising from 12.97% to 14.94%.